Apomorphine (hydrochloride)

Apomorphine (hydrochloride)

• CAS Number: 314-19-2
• UNSPSC Description: Apomorphine ((-)-Apomorphine) hydrochloride is an orally active agonist of Dopamine receptor. Apomorphine hydrochloride can be used in study Parkinson, biphasic dyskinesias, urinary dysfunction, dystonia, dyspnoea, anismus and belching[1][2].
• Target Antigen: 5-HT Receptor; Dopamine Receptor
• Type: Reference compound
• Related Pathways: GPCR/G Protein;Neuronal Signaling
• Field of Research: Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/apomorphine-hydrochloride.html
• Smiles: OC1=CC=C2C(C3=C4C(CCN(C)[C@]4([H])C2)=CC=C3)=C1O.Cl
• Molecular Weight: 303.78
• References & Citations: [1]Frankel JP, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):96-101.|[2]Carbone F, et al. Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs. 2019 Sep;33(9):905-918.Sci Rep. 2019 Jan 22;9(1):254. |Andrologia. 2019 Feb;51(1):e13160.|Andrology. 2022 Mar 2.|Asian J Androl. 2018 Sep-Oct;20(5):448-453.|J Sex Med. 2018 Feb;15(2):136-147. |Oxid Med Cell Longev. 2018 Jun 26;2018:2917981. |Funct Integr Genomics. 2024 Sep 17;24(5):161.
• Shipping Conditions: Room temperature
• Clinical Information: Launched